Replies to post #47963 on WEALTH UNIVERSITY

[jimmenknee]

Thanks for bringing those up jereygirl :-) That particular Industry group was next in line. Although both those companies did not show up on my scan, I'll add them here & show the more full number breakout. My interpretation of the data favors the revenue growth potential for both LMNX (41.56%) & ILMN (98.71%), but they take data hits on profitability. ILMN's FL is higher than my threshold, but their EPS growth, PSR & PEG numbers are very favorable. LMNX's FL is favorable, but their EPS growth, PSR & PEG numbers are outside the threshold I'd like to see.

Screener Part 3: Healthcare sector Drugs & Biotechnology industry

 
 Ticker//Tot Ret YTD//PE FWD//PE TTM//ROA TTM//ROE TTM//Rev G 1Yr// 
 IDXX    -30.87       18.28   21.79   13.39    29.09    24.82 
 VPHM     20.53       37.59    9.38   12.29    16.82    21.89 
 ILMN     -5.57       30.58   81.3   -28.18    10.09    98.71 
 LMNX     20.81       65.79   89.29   -2.19     5.24    41.56 
  
 Ticker//% -52w//Grow//Profit//Fin Health//FL Last Q//Proj EPS//PSR//PEG  
 IDXX    37.33%    B      B       A         1.79        21.00%  2.59  1.00 
 VPHM    36.87%    A      ---     B         1.52       -23.00%  3.61  1.85 
 ILMN    41.56%    A      F       B         2.02        58.00%  1.71  1.00 
 LMNX    27.33%    B      F       A         1.12      -100.00%  7.67  4.38 
 

How many legs does a dog have if you call the tail a leg? Four; calling a tail a leg doesn't make it a leg.
Abraham Lincoln